Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada.
暂无分享,去创建一个
L. Boulet | C. Lemière | B. Rowe | F. Ducharme | M. Lougheed | J. FitzGerald | R. Leigh | S. Dell | C. Licskai | A. Becker | D. Bowie
[1] L. Boulet,et al. Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults. , 2010, Canadian respiratory journal.
[2] A. Bell,et al. Management of asthma in adults , 2009, Canadian Medical Association Journal.
[3] L. Boulet,et al. Safety and Effectiveness of Long-Acting Inhaled -Agonist Bronchodilators When Taken with Inhaled Corticosteroids , 2006, Annals of Internal Medicine.
[4] P. Dorinsky,et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. , 2006, Chest.
[5] L. Boulet,et al. Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. , 2005, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[6] L. Boulet,et al. Adult Asthma Consensus Guidelines update 2003. , 2004, Canadian respiratory journal.
[7] Pierre Ernst,et al. Canadian asthma consensus report, 1999 , 1999 .
[8] P. Ernst,et al. Canadian Asthma Consensus Conference Summary of Recommendations , 1996 .